Die Expression von Survivin und seine Relevanz für die Cisplatin-Resistenz von Keimzelltumoren

E. Rajpert-De Meyts, N. Jørgensen, J. Müller, N. E. Skakkebaek, A. Giwercman, N. Graem, Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Laboratory Investigation. ,vol. 72, pp. 223- 231 ,(1995)

Piotr Smolewski, Terameprocol, a novel site-specific transcription inhibitor with anticancer activity. IDrugs : the investigational drugs journal. ,vol. 11, pp. 204- 214 ,(2008)

Hong-Fei Ji, Jing-Lei Liu, Rui Kong, Yan Wang, Ji Jiang, Yu-Zhi Shi, Yan-Mei Yang, Inhibition of survivin expression and mechanisms of reversing drug-resistance of human lung adenocarcinoma cells by siRNA. Chinese Medical Journal. ,vol. 123, pp. 2901- 2907 ,(2010)

Meenal Padhiar, Karen Walker, AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1. IDrugs : the investigational drugs journal. ,vol. 13, pp. 7- 9 ,(2010)

Anne E O’Connor, David M de Kretser, Inhibins in normal male physiology Seminars in Reproductive Medicine. ,vol. 22, pp. 177- 185 ,(2004) , 10.1055/S-2004-831893

Dario C. Altieri, Toshiyuki Tenjo, Cai-De Lu, Nobuhiko Tanigawa, Masao Toyoda, Hiroshi Kawasaki, Inhibition of Apoptosis by Survivin Predicts Shorter Survival Rates in Colorectal Cancer Cancer Research. ,vol. 58, pp. 5071- 5074 ,(1998)

Christian Gisselbrecht, Philippe Gaulard, Dario C. Altieri, Hervé Dombret, Colette Adida, Gilles Salles, Eric Lepage, Josette Briere, Pierre Morel, Felix Reyes, Corinne Haioun, Jacques Diebold, Thierry J. Molina, Prognostic significance of survivin expression in diffuse large B-cell lymphomas Blood. ,vol. 96, pp. 1921- 1925 ,(2000) , 10.1182/BLOOD.V96.5.1921

Petra Diestelkoetter, Jacques Rohayem, Bernd Weigle, Ernst Peter Rieber, Marc Schmitz, Antje Oehmichen, Karsten Conrad, Juergen Mehlhorn, Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Research. ,vol. 60, pp. 1815- 1817 ,(2000)

Bruce D. Cheson, Nancy L. Bartlett, Julie M. Vose, Andres Lopez-Hernandez, Amanda L. Seiz, Anne T. Keating, Setareh Shamsili, A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma. Cancer. ,vol. 118, pp. 3128- 3134 ,(2012) , 10.1002/CNCR.26510

Fengzhi Li, Elizabeth J. Ackermann, C. Frank Bennett, Annette L. Rothermel, Janet Plescia, Simona Tognin, Antonello Villa, Pier Carlo Marchisio, Dario C. Altieri, Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Biology. ,vol. 1, pp. 461- 466 ,(1999) , 10.1038/70242